
CJC-1295 (DAC)
CJC-1295 (DAC)
Long-Acting Growth Hormone Stimulation • Recovery • Fat Loss • Anti-Aging


Benefits of CJC-1295 DAC
Fat Loss & Metabolic Support
Increases basal metabolic rate
Enhances lipolysis (fat breakdown)
Reduces visceral fat
Improves body composition
Muscle Growth & Recovery
Boosts IGF-1 for muscle repair
Speeds recovery after training
Helps connective tissue healing
Supports lean muscle preservation during dieting
Sleep, Mood & Cognitive Benefits
Improves deep-wave sleep
Enhances REM sleep quality
Supports mental clarity & mood
Anti-Aging & Longevity
Improves skin elasticity
Enhances collagen production indirectly
Supports mitochondrial health
How CJC-1295 DAC Works (Mechanisms of Action)
1. Stimulates the GHRH Receptor
CJC-1295 binds to the Growth Hormone Releasing Hormone (GHRH) receptor, triggering natural GH pulses.
2. Long-acting DAC Technology
The “DAC” modification binds to serum albumin, creating an ultra-long half-life:
30x longer than CJC without DAC
Requires only 1 injection per week
3. Increases Growth Hormone & IGF-1 Levels
Studies show:
GH increases by >200%
IGF-1 increases for 6–8 days
This improves:
Fat metabolism
Muscle repair
Recovery after exercise
Sleep quality
Tissue healing
4. Supports Metabolism & Recovery
GH influences:
Lipolysis (fat burning)
Protein synthesis
Connective tissue repair
Mitochondrial growth
CJC-1295 can significantly enhance the body’s natural regeneration processes.
What Is CJC-1295 DAC?
CJC-1295 (with DAC — Drug Affinity Complex) is a long-acting GHRH analog designed to increase natural growth hormone (GH) and IGF-1 levels in a stable, controlled way.
Unlike older GH therapies, CJC-1295 preserves your natural pulsatile GH release, meaning:
No receptor burnout
No abnormal hormone spikes
No suppression of natural GH production
CJC-1295 DAC attaches to albumin, extending its half-life to ~6–8 days, allowing once-weekly dosing.
It is widely used for:
Fat loss
Muscle recovery
Tissue repair
Metabolic enhancement
Sleep quality
Anti-aging & longevity
GH/IGF-1 support in adults




Dosage, Injection Volume & Cycling
Concentration:
2 mg / 2 ml (1 mg/ml)
Dose:
2 mg once weekly
Injection Volume:
2 mg = 2 ml SC (one vial per week)
Synergy Stacks
Anti-Aging & Skin
CJC-1295 + Epithalon + NAD+
For Fat Loss & Body Recomposition
CJC-1295 + Ipamorelin
→ Dual GH support for fat burning & lean massCJC-1295 + Retatrutide
→ GLP-1 + GH synergy for metabolic transformation
All treatments include a brief consultation and are supervised by qualified clinicians.
Who Is CJC-1295 Ideal For?
Recommended for individuals who want:
Faster recovery from training
Fat loss & improved metabolic rate
Improved sleep & stress resilience
Support during aging or low GH symptoms
Enhanced physical performance
A safe, stable way to raise GH & IGF-1
Suitable for men & women across a range of goals.
Cycle:
12 weeks on → 4 weeks off
Safe to repeat for multiple cycles per year.
Injection Sites:
Abdomen
Upper thigh
Glute
Rotating weekly
For Healing & Recovery
CJC-1295 + BPC-157
CJC-1295 + TB-500
Safety & Side Effects
CJC-1295 is well tolerated.
Possible mild effects:
Temporary injection site irritation
Water retention (rare)
Headache (rare)
Flushing
Avoid if:
Pregnant or breastfeeding
Active cancer or tumour history
(Only applies to uncontrolled cancers)
CJC-1295 DAC — Scientific Research & Clinical Studies
Prolonged GH & IGF-1 stimulation in adults – Randomised, placebo-controlled trials in healthy adults showing long-acting CJC-1295 increases GH and IGF-1 with good safety. PubMed+1
https://pubmed.ncbi.nlm.nih.gov/16352683/
https://academic.oup.com/jcem/article/91/3/799/2843281
GH pulsatility preserved with CJC-1295 – Study demonstrates higher mean GH and IGF-1 with preserved pulsatile secretion in adults. PubMed
https://pubmed.ncbi.nlm.nih.gov/17018654/
Animal model – growth restoration – CJC-1295 normalises growth in GHRH knockout mice via sustained GHRH analogue activity. PubMed
https://pubmed.ncbi.nlm.nih.gov/16822960/
Clinical Disclaimer
The information provided is based on clinical studies, peer-reviewed research, and scientific literature. Peptide therapy is offered as a research-based treatment at The NAD Clinic and is not intended to diagnose, treat, or cure disease. All protocols are medically supervised and personalised to individual needs.



